The University of Arizona College of Medicine – Tucson, located in Tucson, Arizona, is one of three MD granting medical schools in the state of Arizona, affiliated with the University of Arizona.

During the past decade, The University of Arizona Medical Center-University Campus conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 40 clinical trials were completed, i.e. on average, 235.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 14 clinical trials were completed. i.e. 466.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The University of Arizona Medical Center-University Campus" #1 sponsor was "SWOG Cancer Research Network" with 17 trials, followed by "Milton S. Hershey Medical Center" with 10 trials sponsored, "Children's Oncology Group" with 9 trials sponsored, "National Cancer Institute (NCI)" with 9 trials sponsored and "University of Arizona" with 9 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The University of Arizona Medical Center-University Campus" #1 collaborator was "National Cancer Institute (NCI)" with 36 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 9 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Biologics, Inc." with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "The University of Arizona Medical Center-University Campus" are "Asthma" (12 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Colorectal Cancer" (3 trials) and "Venous Leg Ulcer" (3 trials). Many other conditions were trialed in "The University of Arizona Medical Center-University Campus" in a lesser frequency.

Most popular intervention types in "The University of Arizona Medical Center-University Campus" are "Drug" (52 trials), "Other" (36 trials), "Biological" (14 trials), "Procedure" (10 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Pharmacological Study" (6 trials), "Placebo" (6 trials), "Quality-of-Life Assessment" (5 trials) and "Questionnaire Administration" (5 trials). Other intervention names were less common.

The vast majority of trials in "The University of Arizona Medical Center-University Campus" are 68 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "The University of Arizona Medical Center-University Campus". undefined are not yet recruiting, 4 are recruiting, 15 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 46 completed trials in The University of Arizona Medical Center-University Campus, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in The University of Arizona Medical Center-University Campus, 4 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".